Health Care & Pharmaceuticals

Monopoly is a huge factor in driving up prices and driving down quality in America’s health care sector. After waves of hospital mergers, most Americans now live in communities where only one or two hospitals still compete for their health care dollars, and where competition among health care insurers has also largely disappeared. Meanwhile, competition in the pharmaceutical industry is stymied by patent monopolies and highly concentrated corporate ownership.

Open Markets Filed Amicus Brief to Seventh Circuit Court in Support of Plaintiffs in Marion Diagnostic Center v. Becton, Dickinson & Co.

Date Published: April 26, 2019

Open Markets Institute filed an amicus brief to the Seventh Circuit Court in support of the plaintiffs in Marion Diagnostic Center v. Becton, Dickinson & Co. The plaintiffs, who are health care providers, allege that Becton, Dickinson & Co. illegally dominated the markets for conventional syringes, safety syringes, and safety IV catheters.

Continue Reading

The Corner Newsletter, January 24, 2019: What Tim Cook Gets Wrong About Privacy — Congressman Proposes Bill to Fight Hospital Consolidation

Date Published: January 25, 2019

Welcome to The Corner. In this issue we point out the shortcomings of Apple CEO Tim Cook’s big plan to promote privacy and highlight one Republican congressman’s ambitious plan to counter hospitals’ monopoly power. We also share two feature articles by Open Markets in the new Washington Monthly on how fighting monopoly can help Democrats win the Senate, and on the secret anti-monopoly powers of the FTC.

Continue Reading

Join the Movement

In America today, wealth and political power are more concentrated than at any point in our country’s history.

The Open Markets Institute, formerly the Open Markets program at New America, was founded to protect liberty and democracy from these extreme -- and growing -- concentrations of private power.

Stay updated

Sign up to stay informed.